Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 290 institutions that hold shares in the stock, with a total of 170 Million shares, which have been reported (via 13F filing form) to have a value of $4.51 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
25,260,971
shares
|
$701 Million
35.94% of portfolio
|
Q3 2024
Reduced 18.67%
|
|
Viking Global Investors LP
|
Nov 14, 2024 Q3 2024 |
25,120,991
shares
|
$698 Million
2.47% of portfolio
|
Q3 2023
Reduced 5.63%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
14,198,856
shares
|
$394 Million
0.01% of portfolio
|
Q3 2024
Added 1.03%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
12,448,272
shares
|
$346 Million
0.01% of portfolio
|
Q2 2024
Added 18.93%
|
|
Aisling Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
6,068,125
shares
|
$169 Million
63.58% of portfolio
|
Q1 2021
Added 52.11%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,962,654
shares
|
$166 Million
0.01% of portfolio
|
Q3 2024
Added 1.85%
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
4,818,012
shares
|
$134 Million
0.07% of portfolio
|
Q3 2024
Added 11.72%
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,894,282
shares
|
$108 Million
1.36% of portfolio
|
Q3 2024
Reduced 11.27%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
3,760,457
shares
|
$104 Million
5.15% of portfolio
|
Q3 2024
Added 3.52%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
3,413,949
shares
|
$94.8 Million
0.01% of portfolio
|
Q3 2024
Added 3.75%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
2,942,114
shares
|
$81.7 Million
0.01% of portfolio
|
Q3 2024
Added 36.43%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
2,827,666
shares
|
$78.5 Million
0.03% of portfolio
|
Q3 2024
Added 15.3%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
2,803,057
shares
|
$77.8 Million
0.08% of portfolio
|
Q3 2024
Added 5.82%
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
2,614,308
shares
|
$72.6 Million
0.01% of portfolio
|
Q3 2024
Added 18.18%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,532,716
shares
|
$70.3 Million
0.05% of portfolio
|
Q2 2023
Added 75.59%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,051,973
shares
|
$57 Million
0.01% of portfolio
|
Q3 2024
Reduced 10.71%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
1,885,754
shares
|
$52.4 Million
0.09% of portfolio
|
Q3 2024
Added 14.55%
|
|
Sc Us (Ttgp), Ltd.
Menlo Park, CA |
Nov 14, 2024 Q3 2024 |
1,860,364
shares
|
$51.7 Million
0.39% of portfolio
|
Q2 2021
Reduced 26.89%
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,858,351
shares
|
$51.6 Million
3.32% of portfolio
|
Q2 2024
Reduced 41.98%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,747,000
shares
|
$48.5 Million
0.22% of portfolio
|
Q3 2024
New holding
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
1,537,803
shares
|
$42.7 Million
0.02% of portfolio
|
Q3 2024
Added 16.91%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
1,532,224
shares
|
$42.5 Million
0.04% of portfolio
|
Q3 2024
Reduced 0.18%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
1,448,470
shares
|
$40.2 Million
6.0% of portfolio
|
Q3 2024
Added 14.54%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,375,742
shares
|
$38.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 3.73%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,284,802
shares
|
$35.7 Million
0.01% of portfolio
|
Q3 2024
Added 8.04%
|